Dawnrays Pharmaceutical Holdings Ltd. (2348) Financial Statements

5 Followers

Dawnrays Pharmaceutical Holdings Ltd. Financial Overview

Dawnrays Pharmaceutical Holdings Ltd.'s market cap is currently HK$1.70B. The company's EPS TTM is HK$0.1404; its P/E ratio is 7.83; and it has a dividend yield of 5.16%. Dawnrays Pharmaceutical Holdings Ltd. is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 1.23B	¥ 1.06B	¥ 1.15B	¥ 1.28B	¥ 1.17B
Gross Profit	¥ 557.40M	¥ 577.63M	¥ 641.52M	¥ 766.68M	¥ 675.36M
Operating Income	¥ 229.65M	¥ 367.91M	¥ 277.42M	¥ 422.41M	¥ 380.76M
EBITDA	¥ 343.66M	¥ 280.49M	¥ 498.94M	¥ 505.19M	¥ 433.89M
Net Income	¥ 213.97M	¥ 564.94M	¥ 326.00M	¥ 358.06M	¥ 358.18M
Balance Sheet
Cash & Short-Term Investments	¥ 1.58B	¥ 1.37B	¥ 1.07B	¥ 993.04M	¥ 830.22M
Total Assets	¥ 4.01B	¥ 4.01B	¥ 3.62B	¥ 3.67B	¥ 3.34B
Total Debt	¥ 77.51M	¥ 34.72M	¥ 120.53M	¥ 8.41M	¥ 23.52M
Net Debt	¥ -1.09B	¥ -1.12B	¥ -785.30M	¥ -803.27M	¥ -554.22M
Total Liabilities	¥ 621.75M	¥ 682.61M	¥ 763.42M	¥ 1.02B	¥ 941.70M
Stockholders' Equity	¥ 3.39B	¥ 3.32B	¥ 2.85B	¥ 2.64B	¥ 2.38B
Cash Flow
Free Cash Flow	¥ 236.01M	¥ 44.58M	¥ 126.39M	¥ 229.90M	¥ 80.07M
Operating Cash Flow	¥ 355.41M	¥ 220.20M	¥ 338.40M	¥ 434.27M	¥ 393.14M
Investing Cash Flow	¥ -368.80M	¥ 205.17M	¥ -387.57M	¥ -175.01M	¥ -284.20M
Financing Cash Flow	¥ -54.99M	¥ -189.44M	¥ 2.07M	¥ -92.70M	¥ -129.75M

Currency in CNY

Dawnrays Pharmaceutical Holdings Ltd. Earnings and Revenue History

Income Statement >

Dawnrays Pharmaceutical Holdings Ltd. Debt to Assets

Balance Sheet >

Dawnrays Pharmaceutical Holdings Ltd. Cash Flow

Cash Flow >

Dawnrays Pharmaceutical Holdings Ltd. Forecast EPS vs Actual EPS

Earnings >